COVID-19大流行期间青光眼管理的首选实践指南
该指南由专家小组基于共识制定,针对COVID-19大流行期间青光眼诊疗实践提出修改和额外防护措施。指南适用于全国范围,旨在帮助眼科医生和青光眼专科医生在封锁放松后安全重启常规诊疗和急诊服务,同时保护患者和医务人员免受感染。指南强调在控制疫情的同时继续以安全和负责任的方式治疗非COVID-19患者。
要点
- 指南由专家小组基于共识制定,适用于全国范围,帮助眼科医生和青光眼专科医生安全重启诊疗。
- 青光眼诊疗实践需要修改和额外防护措施,兼顾患者和医务人员安全。
- 封锁放松期间需同时处理常规患者和急诊服务。
- 指南旨在在控制疫情的同时继续安全和负责地治疗非COVID-19患者。
适用人群与场景
- 适用于全国范围内的眼科医生和青光眼专科医生,在COVID-19大流行期间及封锁放松后重启青光眼诊疗实践时使用。
处置流程与药物剂量
- 青光眼诊疗实践需进行修改并采取额外防护措施,以保护患者和医务人员安全。
- 在封锁放松期间,需同时学习处理常规患者和急诊服务。
研究设计与关键结果
- 本文提出专家小组基于共识的指南,指导如何在COVID-19期间重启青光眼诊疗实践。
证据类型、等级与局限
- 证据类型:专家小组基于共识的指南。
- 局限:原文未报告局限性。
对床旁实践的改变
- 眼科医生和青光眼专科医生可依据本指南在封锁放松后安全重启诊疗,同时处理常规患者和急诊服务,并采取额外防护措施。
指南或共识出处
- 指南名称:COVID-19大流行期间青光眼管理的首选实践指南(Preferred practice guidelines for glaucoma management during COVID-19 pandemic);发布机构:印度眼科杂志(Indian J Ophthalmol);年份:原文未明确。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The COVID-19 pandemic has threatened the humanity at a global level to a large extent by the burden of the disease with significant mortality and to a certain extent as a byproduct of the necessary efforts to contain the same. There is a significant impact on the health care system, as we not only have to contain pandemic, but continue to treat our non-COVID-19 patients in a safe and responsible manner. Ophthalmology practice in general and glaucoma in particular needs certain modifications and additional precautions while examining as well as managing these patients keeping their and our safety in mind. As the lockdown relaxations are in vogue we need to learn how to deal with our regular patients as well in addition to emergency care. This paper presents the consensus-based guidelines by an expert panel on how to restart glaucoma practice during this COVID-19 time. These guidelines will be applicable across the country and should help ophthalmologists and glaucoma specialist to restart their practices while safeguarding the patients and their own selves from getting infected.
参考来源
- Tejwani S, Angmo D, Nayak BK, et al. Preferred practice guidelines for glaucoma management during COVID-19 pandemic. Indian J Ophthalmol. 2020. PMID: 32587151. doi:10.4103/ijo.IJO_1724_20
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。